The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
Open accessAbstract
Hypertension and heart failure (HF) are common diseases that, despite advances in medical therapy, continue to be associated with high morbidity and mortality. Therefore, innovative therapeutic strategies are needed. Inhibition of the neutral endopeptidase (NEPinh) had been investigated as a potential novel therapeutic approach because of its ability to increase the plasma concentrations of the natriuretic peptides (NPs). Indeed, the NPs have potent natriuretic and vasodilator properties, inhibit the activity of the renin-angiotensin-aldosterone system, lower sympathetic drive, and have antiproliferative and antihypertrophic effects. Such potentially beneficial effects can be theoretically achieved by the use of NEPinh. However, studies have shown that NEPinh alone does not result in clinically meaningful blood pressure-lowering actions. More recently, NEPinh has been used in combination with other cardiovascular agents, such as angiotensin-converting enzyme inhibitors, and antagonists of the angiotensin receptor. Another future possible combination would be the use of NEPinh with NPs or their newly developed chimeric peptides. This review summarizes the current knowledge of the use and effects of NEPinh alone or in combination with other therapeutic agents for the treatment of human cardiovascular disease such as HF and hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Bold, A. J., Borenstein, H. B., Veress, A. T., & Sonnenberg, H. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90370-2 · Cited by 3,148
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
The International Consortium for Blood Pressure Genome-Wide Association Studies (2011) · Nature · doi:10.1038/nature10405 · Cited by 2,033
A new natriuretic peptide in porcine brain
Sudoh, T., Kangawa, K., Minamino, N., & Matsuo, H. (1988) · Nature · doi:10.1038/332078a0 · Cited by 1,816
Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., & Yasue, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115146 · Cited by 1,354
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
O'Connor, C. M., Starling, R. C., Hernandez, A. F., Armstrong, P. W., Dickstein, K., Hasselblad, V., Heizer, G. M., Komajda, M., Massie, B. M., McMurray, J. J. V., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100171 · Cited by 1,252
Impact of Obesity on Plasma Natriuretic Peptide Levels
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Wilson, P. W. F., & Vasan, R. S. (2004) · Circulation · doi:10.1161/01.cir.0000112582.16683.ea · Cited by 1,022
(2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00795-x · Cited by 980
Colucci, W. S., Elkayam, U., Horton, D. P., Abraham, W. T., Bourge, R. C., Johnson, A. D., Wagoner, L. E., Givertz, M. M., Liang, C.-S., Neibaur, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430403 · Cited by 911
Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the Human
Burnett, J. C., Kao, P. C., Hu, D. C., Heser, D. W., Heublein, D., Granger, J. P., Opgenorth, T. J., & Reeder, G. S. (1986) · Science · doi:10.1126/science.2935937 · Cited by 891
Self-citationBordicchia, M., Liu, D., Amri, E.-Z., Ailhaud, G., Dessì-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R., & Collins, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59701 · Cited by 872
Effects of synthetic atrial natriuretic factor on renal function and renin release
Burnett, J. C. J., Granger, J. P., & Opgenorth, T. J. (1984) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1984.247.5.f863 · Cited by 659
Self-citationHigh-affinity enkephalin-degrading peptidase in brain is increased after morphine
MALFROY, B., SWERTS, J. P., GUYON, A., ROQUES, B. P., & SCHWARTZ, J. C. (1978) · Nature · doi:10.1038/276523a0 · Cited by 642
Packer, M., Califf, R. M., Konstam, M. A., Krum, H., McMurray, J. J., Rouleau, J.-L., & Swedberg, K. (2002) · Circulation · doi:10.1161/01.cir.0000029801.86489.50 · Cited by 621
Konstam, M. A., Rousseau, M. F., Kronenberg, M. W., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S., & Kinan, D. (1992) · Circulation · doi:10.1161/01.cir.86.2.431 · Cited by 601
Ruilope, L. M., Dukat, A., Böhm, M., Lacourcière, Y., Gong, J., & Lefkowitz, M. P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61966-8 · Cited by 599
Kostis, J. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.09.014 · Cited by 579
(2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432019 · Cited by 526
Gu, J., Noe, A., Chandra, P., Al‐Fayoumi, S., Ligueros‐Saylan, M., Sarangapani, R., Maahs, S., Ksander, G., Rigel, D. F., Jeng, A. Y., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009343932 · Cited by 505
Emoto, N., & Yanagisawa, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15262 · Cited by 499
The purification and specificity of a neutral endopeptidase from rabbit kidney brush border
Kerr, M. A., & Kenny, A. J. (1974) · Biochemical Journal · doi:10.1042/bj1370477 · Cited by 460
Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX
Turner, A. J., & Tanzawa, K. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141502 · Cited by 402
Newton-Cheh, C., Larson, M. G., Vasan, R. S., Levy, D., Bloch, K. D., Surti, A., Guiducci, C., Kathiresan, S., Benjamin, E. J., Struck, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.328 · Cited by 398
Rouleau, J. L., Pfeffer, M. A., Stewart, D. J., Isaac, D., Sestier, F., Kerut, E. K., Porter, C. B., Proulx, G., Qian, C., & Block, A. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02602-7 · Cited by 396
Natriuretic peptide metabolism, clearance and degradation
Potter, L. R. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08082.x · Cited by 357
Konstam, M. A., Kronenberg, M. W., Rousseau, M. F., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S., & Kinan, D. (1993) · Circulation · doi:10.1161/01.cir.88.5.2277 · Cited by 316
Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases
Tsuruda, T., Boerrigter, G., Huntley, B. K., Noser, J. A., Cataliotti, A., Costello-Boerrigter, L. C., Chen, H. H., & Burnett, J. C. (2002) · Circulation Research · doi:10.1161/01.res.0000046234.73401.70 · Cited by 301
Self-citationKenny, A. J., Bourne, A., & Ingram, J. (1993) · Biochemical Journal · doi:10.1042/bj2910083 · Cited by 293
Miyashita, K., Itoh, H., Tsujimoto, H., Tamura, N., Fukunaga, Y., Sone, M., Yamahara, K., Taura, D., Inuzuka, M., Sonoyama, T., et al. (2009) · Diabetes · doi:10.2337/db09-0393 · Cited by 288
Hawkridge, A. M., Heublein, D. M., Bergen, H. R., Cataliotti, A., Burnett, J. C., & Muddiman, D. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508782102 · Cited by 266
Self-citationNatriuretic peptide receptor-C signaling and regulation
Anand-Srivastava, M. B. (2005) · Peptides · doi:10.1016/j.peptides.2004.09.023 · Cited by 265
Tsukamoto, O., Fujita, M., Kato, M., Yamazaki, S., Asano, Y., Ogai, A., Okazaki, H., Asai, M., Nagamachi, Y., Maeda, N., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.038 · Cited by 254
Hypertension in mice lacking the proatrial natriuretic peptide convertase corin
Chan, J. C. Y., Knudson, O., Wu, F., Morser, J., Dole, W. P., & Wu, Q. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407234102 · Cited by 249
The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase).
Vijayaraghavan, J., Scicli, A. G., Carretero, O. A., Slaughter, C., Moomaw, C., & Hersh, L. B. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77280-3 · Cited by 245
Ruffolo, R. R., & Feuerstein, G. Z. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199800003-00005 · Cited by 210
Molecular physiology of natriuretic peptide signalling
Kuhn, M. (2004) · Basic Research in Cardiology · doi:10.1007/s00395-004-0460-0 · Cited by 195
Dries, D. L., Victor, R. G., Rame, J. E., Cooper, R. S., Wu, X., Zhu, X., Leonard, D., Ho, S.-I., Wu, Q., Post, W., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.568881 · Cited by 195
Kerr, M. A., & Kenny, A. J. (1974) · Biochemical Journal · doi:10.1042/bj1370489 · Cited by 187
Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors
Adam, A., Cugno, M., Molinaro, G., Perez, M., Lepage, Y., & Agostoni, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08914-6 · Cited by 181
Inhibition of Neutral Endopeptidase Causes Vasoconstriction of Human Resistance Vessels In Vivo
Ferro, C. J., Spratt, J. C., Haynes, W. G., & Webb, D. J. (1998) · Circulation · doi:10.1161/01.cir.97.23.2323 · Cited by 175
Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension
Bevan, E. G., Connell, J. M. C., Doyle, J., Carmichael, H. A., Davies, D. L., Lorimer, A. R., & Mclnnes, G. T. (1992) · Journal of Hypertension · doi:10.1097/00004872-199207000-00002 · Cited by 175
Neprilysin, obesity and the metabolic syndrome
Standeven, K. F., Hess, K., Carter, A. M., Rice, G. I., Cordell, P. A., Balmforth, A. J., Lu, B., Scott, D. J., Turner, A. J., Hooper, N. M., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.227 · Cited by 174
Vasopeptidase inhibition: a new concept in blood pressure management.
Burnett, J. C. J. (1999) · PubMed · Cited by 171
Self-citationNiederkofler, E. E., Kiernan, U. A., O'Rear, J., Menon, S., Saghir, S., Protter, A. A., Nelson, R. W., & Schellenberger, U. (2008) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.790774 · Cited by 165
Cilia La Corte, A. L., Carter, A. M., Rice, G. I., Duan, Q. L., Rouleau, G. A., Adam, A., Grant, P. J., & Hooper, N. M. (2011) · Human Mutation · doi:10.1002/humu.21579 · Cited by 154
Magnusson, M., Jujić, A., Hedblad, B., Engström, G., Persson, M., Struck, J., Morgenthaler, N. G., Nilsson, P. M., Newton‐Cheh, C., Wang, T. J., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2425 · Cited by 152
Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans
Birkenfeld, A. L., Budziarek, P., Boschmann, M., Moro, C., Adams, F., Franke, G., Berlan, M., Marqués, M.-A., Sweep, F. C. G. J., Luft, F. C., et al. (2008) · Diabetes · doi:10.2337/db08-0649 · Cited by 147
Hoover, T. A., Lippmann, M. L., Grouzmann, E., Marceau, F., & Herscu, P. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03323.x · Cited by 137
Obesity and the Metabolic Syndrome
Keller, K. B., & Lemberg, L. (2003) · American Journal of Critical Care · doi:10.4037/ajcc2003.12.2.167 · Cited by 136
Fryer, R. M., Segreti, J., Banfor, P. N., Widomski, D. L., Backes, B. J., Lin, C. W., Ballaron, S. J., Cox, B. F., Trevillyan, J. M., Reinhart, G. A., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707641 · Cited by 130 · cited 1×
“We now know that inhibition of aminopeptidase P (APP), which was also potently inhibited by omapatrilat, is an important consideration.(96) Aminopeptidase P has a role both in BK degradation when ACE is inhibited and in the inactivation of the pro-inflammatory BK metabolite, des-Arg(9)-BK.”
BackgroundDuan, Q. L., Nikpoor, B., Dubé, M.-P., Molinaro, G., Meijer, I. A., Dion, P., Rochefort, D., Saint-Onge, J., Flury, L., Brown, N. J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/496899 · Cited by 126 · cited 1×
“Similarly, individuals with XPNPEP2 genetic variations that result in lower APP levels are also more apt to have ACE-inhibitor-associated angioedema.(98,99) In this age of pharmacogenomics and personalized therapy, the incidence of angioedema may be decreased by not giving genetically predisposed subjects such a medic…”
BackgroundMiller, W. L., Phelps, M. A., Wood, C. M., Schellenberger, U., Le, A. V., Périchon, R., & Jaffe, A. S. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.960260 · Cited by 120
Lee, C. Y. W., Chen, H. H., Lisý, O., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009336233 · Cited by 111
Ichiki, T., Huntley, B. K., Heublein, D. M., Sandberg, S. M., McKie, P. M., Martín, F. L., Jougasaki, M., & Burnett, J. C. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.153908 · Cited by 109
Self-citationCharles, C. J., Espiner, E. A., Nicholls, M. G., et al. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.2.r373 · Cited by 105
Cannone, V., Boerrigter, G., Cataliotti, A., Costello‐Boerrigter, L. C., Olson, T. M., McKie, P. M., Heublein, D. M., Lahr, B. D., Bailey, K. R., Averna, M. R., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.011 · Cited by 103
Self-citationMacheret, F., Heublein, D. M., Costello‐Boerrigter, L. C., Boerrigter, G., McKie, P. M., Bellavia, D., Mangiafico, S., Ikeda, Y., Bailey, K. R., Scott, C. G., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.049 · Cited by 102
Self-citationCataliotti, A., Tonne, J. M., Bellavia, D., Martín, F. L., Oehler, E. A., Harders, G. E., Campbell, J. M., Peng, K.-W., Russell, S. J., Malatino, L., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.981720 · Cited by 89
Self-citationNext generation multifunctional angiotensin receptor blockers
Kurtz, T. W., & Klein, U. (2009) · Hypertension Research · doi:10.1038/hr.2009.135 · Cited by 80
Recent advances in natriuretic peptides in congestive heart failure
Boerrigter, G., & Burnett, J. C. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.6.643 · Cited by 79
Self-citationMeirhaeghe, A., Sandhu, M. S., McCarthy, M. I., de Groote, P., Cottel, D., Arveiler, D., Ferrières, J., Groves, C. J., Hattersley, A. T., Hitman, G. A., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm084 · Cited by 78
Pro–B-Type Natriuretic Peptide1–108 Circulates in the General Community
Macheret, F., Boerrigter, G., McKie, P. M., Costello‐Boerrigter, L. C., Lahr, B. D., Heublein, D. M., Sandberg, S. M., Ikeda, Y., Cataliotti, A., Bailey, K., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.005 · Cited by 75
Self-citationChen, H. H., Schirger, J. A., Chau, W. L., Jougasaki, M., Lisý, O., Redfield, M. M., Barclay, P. T., & Burnett, J. C. J. (1999) · Circulation · doi:10.1161/01.cir.100.24.2443 · Cited by 66
Self-citationAngiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth
Sarzani, R., Marcucci, P., Salvi, F., Bordicchia, M., Espinosa, E., Mucci, L., Lorenzetti, B., Minardi, D., Muzzonigro, G., Dessì-Fulgheri, P., et al. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803724 · Cited by 65
Dickey, D. M., & Potter, L. R. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.03.013 · Cited by 63
Belluardo, P., Cataliotti, A., Bonaiuto, L., Giuffré, E., Maugeri, E., Noto, P., Orlando, G., Raspa, G., Piazza, B., Babuin, L., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00107.2006 · Cited by 61
Self-citationSecretion of Glycosylated Pro–B-Type Natriuretic Peptide from Normal Cardiomyocytes
Tonne, J. M., Campbell, J. M., Cataliotti, A., Ohmine, S., Thatava, T., Sakuma, T., Macheret, F., Huntley, B. K., Burnett, J. C. J., & Ikeda, Y. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.157438 · Cited by 60
Self-citationPiller, L. B., Baraniuk, S., Simpson, L. M., Cushman, W. C., Massie, B. M., Einhorn, P. T., Oparil, S., Ford, C. E., Graumlich, J. F., Dart, R. A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.012575 · Cited by 54
cGMP rescues mitochondrial dysfunction induced by glucose and insulin in myocytes
Mitsuishi, M., Miyashita, K., & Itoh, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.017 · Cited by 48
C-type natriuretic peptide: new candidate for endothelium-derived hyperpolarising factor
Chauhan, S. D., Hobbs, A. J., & Ahluwalia, A. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.09.009 · Cited by 37
Choquet, H., Cavalcanti-Proença, C., Lecœur, C., Dina, C., Cauchi, S., Vaxillaire, M., Hadjadj, S., Horber, F., Potoczna, N., Charpentier, G., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp169 · Cited by 37
Cataliotti, A., Costello‐Boerrigter, L. C., Chen, H. H., Textor, S. C., & Burnett, J. C. J. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.02.003 · Cited by 29
Self-citationB-Type Natriuretic Peptide Decreases Gastric Emptying and Absorption
Addisu, A., Gower, W. R., Landon, C. S., & Dietz, J. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0708-rm-216 · Cited by 25
Omapatrilat. Bristol-Myers Squibb.
Tabrizchi, R. (2001) · PubMed · Cited by 21
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft052 · Cited by 457
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0141 · Cited by 444
Metadata
- Authors
- Mangiafico, S., Costello-Boerrigter, L. C., Andersen, I. A., Cataliotti, A., & Burnett, J. C.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-31
- Volume
- 34
- Issue
- 12
- Pages
- 886-893
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2108076556
- Cited by
- 276
- References
- 74
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.